A Senescence-Centric View of Aging: Implications for Longevity and Disease

生物 长寿 衰老 促炎细胞因子 机制(生物学) 细胞衰老 细胞生物学 神经科学 免疫学 炎症 遗传学 基因 表型 哲学 认识论
作者
Michela Borghesan,Willem M.H. Hoogaars,Marta Varela-Eirín,Nynke Talma,Marco Demaria
出处
期刊:Trends in Cell Biology [Elsevier BV]
卷期号:30 (10): 777-791 被引量:262
标识
DOI:10.1016/j.tcb.2020.07.002
摘要

There is increasing evidence of the detrimental role of senescent cells in aging. Clearance of senescent cells has been shown to improve age-associated pathologies in animal models, leading to promising new clinical trials. Different mechanisms of senescent cells can be exploited pharmacologically to develop new therapeutic targets. Cellular senescence is a state of stable cell cycle arrest associated with macromolecular alterations and secretion of proinflammatory cytokines and molecules. From their initial discovery in the 1960s, senescent cells have been hypothesized as potential contributors to the age-associated loss of regenerative potential. Here, we discuss recent evidence that implicates cellular senescence as a central regulatory mechanism of the aging process. We provide a comprehensive overview of age-associated pathologies in which cellular senescence has been implicated. We describe mechanisms by which senescent cells drive aging and diseases, and we discuss updates on exploiting these mechanisms as therapeutic targets. Finally, we critically analyze the use of senotherapeutics and their translation to the clinic, highlighting limitations and suggesting ideas for future applications and developments. Cellular senescence is a state of stable cell cycle arrest associated with macromolecular alterations and secretion of proinflammatory cytokines and molecules. From their initial discovery in the 1960s, senescent cells have been hypothesized as potential contributors to the age-associated loss of regenerative potential. Here, we discuss recent evidence that implicates cellular senescence as a central regulatory mechanism of the aging process. We provide a comprehensive overview of age-associated pathologies in which cellular senescence has been implicated. We describe mechanisms by which senescent cells drive aging and diseases, and we discuss updates on exploiting these mechanisms as therapeutic targets. Finally, we critically analyze the use of senotherapeutics and their translation to the clinic, highlighting limitations and suggesting ideas for future applications and developments. diseases whose incidence increases with aging, most of them sharing an inflammatory pathogenesis and correlating with increased levels of cell senescence. molecular and cellular damage accumulation over time leading to a progressive decline in physical and mental capacity, and to an increased risk for disease and death. programmed and controlled cell death that regulates growth, development, tissue homeostasis, and tumor suppression. heterogeneous cell state in response to different stress stimuli, characterized by stable cell cycle arrest, as well as morphological, structural, and functional changes, including enhanced expression and secretion of proinflammatory mediators. clinical syndrome observed in older adults that predispose to poor health, onset and progression of diseases and decreased capacity to cope with cellular and tissue stress. conversion from reversible cell cycle arrest (quiescence) to irreversible cell cycle arrest (senescence). period of life where an individual has good health, free of disabilities and diseases. gradual age-associated functional decline of the immune system, especially of the adaptative immune system, that contributes to increased risk of morbidity and mortality. low-grade chronic inflammation, not induced by pathogens, causing higher risk of morbidity and mortality in elderly. measure of populations average survival time between birth and death. cellular senescence originated from dysfunctional mitochondria, likely as a result of the accumulation of ROS. regulated degradation of dysfunctional mitochondria by autophagy. cellular senescence originated in a non-cell autonomous manner via SASP factors secreted by neighboring senescent cells. syndrome or phenotype mimicking premature aging. robust and heterogeneous secretion of soluble modulators by senescent cells, including cytokines, chemokines, growth factors, proteases, and EVs. molecules and strategies that target cellular senescence, which can be classified as senolytics (selective elimination of senescent cells via programmed cell death) and senomorphics/senostatics (modulation of senescence-associated phenotypes without senolysis).
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
Gaiiw发布了新的文献求助10
刚刚
1秒前
成就的问枫完成签到 ,获得积分10
1秒前
wanci的应助被jeff采纳,获得10
1秒前
浪荡的小可完成签到,获得积分10
2秒前
我有神光棒完成签到,获得积分10
2秒前
威武的沂完成签到,获得积分10
2秒前
Zoe_Zhang完成签到,获得积分10
2秒前
2秒前
深情安青的应助被懵懂的听枫采纳,获得10
2秒前
小艾发布了新的文献求助10
3秒前
清脆紫烟发布了新的文献求助10
3秒前
3秒前
烟花的应助被噗喵喵采纳,获得10
4秒前
阿May发布了新的文献求助10
5秒前
GFFino完成签到 ,获得积分10
6秒前
GZH完成签到,获得积分10
6秒前
ygchyh完成签到,获得积分10
7秒前
lilili发布了新的文献求助10
8秒前
8秒前
9秒前
之鱼之乐发布了新的文献求助10
9秒前
好听点啊完成签到 ,获得积分10
10秒前
11秒前
molihuakai的应助被东京蔡徐坤采纳,获得10
11秒前
Maestro_S的应助被renn采纳,获得30
11秒前
一叶瓷完成签到,获得积分10
11秒前
尘远知山静完成签到 ,获得积分10
12秒前
12秒前
宋囡囡完成签到,获得积分10
15秒前
zrj完成签到,获得积分10
15秒前
16秒前
王小拉完成签到 ,获得积分10
16秒前
16秒前
小琴子完成签到,获得积分10
16秒前
jeff发布了新的文献求助10
16秒前
爪子完成签到,获得积分10
16秒前
17秒前
Zurini完成签到,获得积分10
17秒前
CJY发布了新的文献求助10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Improving the wear resistance of vehicle gear oil by oil soluble LaF3 nanoparticles and typical additives of gear oil 500
Boundaries and Bodhisattvas 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8184061
求助须知:如何正确求助?哪些是违规求助? 9573151
关于积分的说明 21829878
捐赠科研通 7781058
什么是DOI,文献DOI怎么找? 3434216
关于科研通互助平台的介绍 2558337
邀请新用户注册赠送积分活动 2480674